Characteristics and survival of African American (AA) newly diagnosed multiple myeloma (NDMM) patients (Pts): A report from the Connect MM Registry.

被引：0
|
作者：
Toomey, Kathleen
Gasparetto, Cristina
Shah, Jatin J.
Abonour, Rafat
Mehta, Jayesh
Narang, Mohit
Terebelo, Howard R.
Hardin, James W.
Srinivasan, Shankar
Larkins, Gail
Ricafort, Rosanna J.
Nagarwala, Yasir M.
Rifkin, Robert M.
机构：
[1] Steeplechase Canc Ctr, Somerville, NJ USA
[2] Duke Univ, Durham, NC USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[5] Northwestern Univ, Chicago, IL 60611 USA
[6] Maryland Oncol Hematol, Columbia, MD USA
[7] Providence Hosp, Southfield, MI 48037 USA
[8] Univ S Carolina, Columbia, SC 29208 USA
[9] Celgene Corp, Summit, NJ USA
[10] US Oncol Res Inc, Denver, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19529
引用
收藏
页数：1
相关论文
共 50 条
  • [41] TOTAL THERAPY (TT) FOR 202 NEWLY-DIAGNOSED PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM)
    BARLOGIE, B
    JAGANNATH, S
    VESOLE, D
    MILLER, L
    CHESON, B
    BRACY, D
    TRICOT, G
    BLOOD, 1994, 84 (10) : A386 - A386
  • [42] Association Of Treatment Induced Peripheral Neuropathy (TIPN) With Treatment Patterns and Outcomes In Patients (pts) With Newly Diagnosed Multiple Myeloma (NDMM)
    Martin, Thomas G., III
    Panjabi, Sumeet
    Kerr, Jiandong
    Martin, Michael G.
    Walker, Mark S.
    BLOOD, 2013, 122 (21)
  • [43] Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM
    Jagannath, Sundar
    Abonour, Rafat
    Durie, Brian G. M.
    Narang, Mohit
    Terebelo, Howard R.
    Gasparetto, Cristina J.
    Toomey, Kathleen
    Hardin, James W.
    Wagner, Lynne
    Agarwal, Amit
    Srinivasan, Shankar
    Kitali, Amani
    Flick, E. Dawn
    Sturniolo, Michael
    Rifkin, Robert M.
    BLOOD ADVANCES, 2018, 2 (13) : 1608 - 1615
  • [44] ANALYSIS OF THE CONNECT MM REGISTRY: TREATMENT OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA WHO RECEIVED LENALIDOMIDE MAINTENANCE OR NO MAINTENANCE
    Rifkin, R. M.
    Jagannath, S.
    Durie, B. G.
    Shah, J. J.
    Narang, M.
    Terebelo, H. R.
    Gasparetto, C. J.
    Toomey, K.
    Hardin, J. W.
    Wagner, L.
    Parikh, K.
    Abouzaid, S.
    Srinivasan, S.
    Kitali, A.
    Zafar, F.
    Abonour, R.
    HAEMATOLOGICA, 2017, 102 : 523 - 524
  • [45] PFS2 In Elderly Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results Fro The MM-015 Study
    Dimopoulos, Meletios A.
    Petrucci, Maria Teresa
    Foa, Robin
    Catalano, John V.
    Kropff, Martin
    Yu, Zhinuan
    Grote, Lara
    Jacques, Christian J.
    Palumbo, Antonio
    BLOOD, 2013, 122 (21)
  • [46] Healthcare Resource Utilization Trends over Time with Continuous Lenalidomide Treatment (Tx) in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM)
    Weisel, Katja
    Vogl, Dan T.
    Delforge, Michel
    Song, Kevin
    Dimopoulos, Meletios
    Cavenagh, Jamie
    Hulin, Cyrille
    Rodon, Philippe
    Arnulf, Bertrand
    Foa, Robin
    Oriol, Albert
    Guo, Shien
    Monzini, Mara Silvia
    Van Oostendorp, Jason
    Ervin-Haynes, Annette
    Facon, Thierry
    BLOOD, 2014, 124 (21)
  • [47] ASSESSMENT OF THE IMPACT OF POST-AUTOLOGOUS STEM CELL TRANSPLANT MAINTENANCE THERAPY ON SURVIVAL OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA IN THE COMMUNITY-BASED CONNECT MM REGISTRY
    Jagannath, S.
    Abonour, R.
    Durie, B. G.
    Shah, J. J.
    Narang, M.
    Terebelo, H. R.
    Gasparetto, C. J.
    Toomey, K.
    Hardin, J. W.
    Wagner, L.
    Agarwal, A.
    Srinivasan, S.
    Kitali, A.
    Zafar, F.
    Sturniolo, M.
    Rifkin, R. M.
    HAEMATOLOGICA, 2017, 102 : 507 - 507
  • [48] Safety results from the phase 3 MajesTEC-7 study in patients (pts) with transplant ineligible/not intended newly diagnosed multiple myeloma (NDMM).
    Touzeau, Cyrille
    Beksac, Meral
    Terpos, Evangelos
    Usmani, Saad Zafar
    Krishnan, Amrita Y.
    Nijhof, Inger S.
    Janowski, Wojciech
    Hulin, Cyrille
    Grosicki, Sebastian
    Delforge, Michel
    McAleer, Dana
    Nagle, Sarah
    Olyslager, Yunsi
    Miller, Jonathan
    Craig, Zoe
    Khan, Josephine
    Kampfenkel, Tobias
    Manier, Salomon
    van de Donk, Niels W. C. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] Triplet Therapy & Overall Survival (OS) in Routine Practice among Transplant-Ineligible Patients (pts) with Newly Diagnosed Multiple Myeloma (NDMM) in the United States (US)
    Romanus, Dorothy
    Raju, Aditya
    Seal, Brian
    Farrelly, Eileen
    Luptakova, Katarina
    Blazer, Marlo
    Parameswaran, Hari
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E80 - E80
  • [50] Comparative analysis of outcomes in African American (AA) and white (W) patients (pts) with multiple myeloma (MM) treated with lenalidomide (LEN) or pomalidomide (POM).
    Ailawadhi, Sikander
    McCarthy, Philip L.
    Holstein, Sarah A.
    Larkins, Gail
    Chung, Weiyuan
    Srinivasan, Shankar
    Agarwal, Amit
    Lonial, Sagar
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345